Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NTRBW - Nutriband Inc - Warrants (30/09/2026)


Previous close
0.95
0   0%

Share volume: 236
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$0.95
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-13.64%
1 Month
-57.78%
3 Months
-5.94%
6 Months
265.38%
1 Year
35.71%
2 Year
-78.84%
Key data
Stock price
$0.95
P/E Ratio 
-7.07
DAY RANGE
N/A - $1.48
EPS 
-$0.77
52 WEEK RANGE
$0.19 - $3.44
52 WEEK CHANGE
$0.40
MARKET CAP 
45.027 M
YIELD 
N/A
SHARES OUTSTANDING 
750.000 K
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$236
AVERAGE 30 VOLUME 
$1,412
Company detail
CEO: Gareth Sheridan
Region: US
Website: https://nutriband.com/
Employees: 7
IPO year: -
Issue type:
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

nutriband inc. is a health and pharmaceutical company based in, oviedo, florida. nutriband's primary focus is on transdermal and topical technologies for product development.

Recent news